Amphastar PharmaceuticalsAMPH

那斯達克 · USD
27.67
+0.12
(+0.44%)
收盤 02/25 04:59 (UTC+8)
02/25 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.46
  • 1.81
  • 1.78
  • 1.72
  • 1.82
  • 1.91
  • 1.87
  • 1.71
  • 1.74
  • 1.92
icon
  • 4.06
  • 23.91
  • -1.36
  • -3.52
  • 6.14
  • 4.84
  • -2.45
  • -8.58
  • 2.28
  • 9.99
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
191,840
174,414
170,528
186,523
191,214
182,394
171,836
178,105
180,556
145,712
營業成本
93,19487,92485,27799,87589,27387,22881,73681,96572,15372,974
營業毛利
98,646
86,490
85,251
86,648
101,941
95,166
90,100
96,140
108,403
72,738
營業費用
73,32644,30647,958-44,89339,94942,09042,16035,72535,842
研發費用
22,35420,08020,09618,14221,07717,65217,04320,41916,66416,843
推銷及管理費用
50,97224,22627,86223,36223,81622,29725,04721,74119,06118,999
非經常性項目費用
----------
其他營業費用
----------
營業利益
25,320
42,184
37,293
45,144
57,048
55,217
48,010
53,980
72,678
36,896
其他收入及費用
2,4773,432-1455,243-2,6673,6358,477-3,1794,661-486
利息費用
6,2846,2816,2866,4256,6988,6098,6119,45613,7023,602
稅前純益
21,513
39,335
30,862
43,962
47,683
50,243
47,876
41,345
63,637
32,808
所得稅
4,1638,3055,5775,9987,25412,2944,1264,67314,0256,383
稅後純益
17,350
31,030
25,285
37,964
40,429
37,949
43,177
36,167
49,222
26,124
基本每股稅後盈餘(元)
0.380.660.530.790.830.770.900.751.010.54
稀釋每股稅後盈餘(元)
0.370.640.510.740.780.730.810.690.920.49
基本平均股數(千股)
46474.0046949.0047641.0047975.0048621.0048907.0048212.0047957.0048701.0048404.00
稀釋平均股數(千股)
47677.0048128.0049890.0051310.0051862.0052046.0053013.0053014.0053921.0053102.00
還原基本每股稅後盈餘(元)
0.380.660.530.790.830.770.900.751.010.54
還原稀釋每股稅後盈餘(元)
0.370.640.510.740.780.730.810.690.920.49
還原基本平均股數(千股)
46,47446,94947,64147,97548,62148,90748,21247,95748,70148,404
還原稀釋平均股數(千股)
47,67748,12849,89051,31051,86252,04653,01353,01453,92153,102
EBITDA(千元)
44,45062,69753,11765,77569,55875,43372,00566,99895,75746,320

大家都在看

HOT